Ceridian HCM Holding Inc (NYSE:CDAY) has been given an average recommendation of “Hold” by the twenty research firms that are currently covering the firm, Marketbeat reports. Two investment analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $66.82.
Several research analysts have commented on CDAY shares. Goldman Sachs Group increased their price objective on shares of Ceridian HCM from $62.00 to $72.00 in a report on Monday, June 29th. Zacks Investment Research raised shares of Ceridian HCM from a “sell” rating to a “hold” rating in a report on Monday, March 30th. Cowen increased their price objective on shares of Ceridian HCM from $69.00 to $85.00 and gave the company an “outperform” rating in a report on Thursday, June 11th. JPMorgan Chase & Co. downgraded shares of Ceridian HCM from a “neutral” rating to an “underweight” rating and set a $45.00 price objective for the company. in a report on Thursday, April 23rd. Finally, Needham & Company LLC increased their price objective on shares of Ceridian HCM from $60.00 to $70.00 and gave the company a “buy” rating in a report on Thursday, May 7th.
Shares of Ceridian HCM stock opened at $84.99 on Friday. The company has a market capitalization of $12.15 billion, a P/E ratio of 166.65 and a beta of 1.68. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.08 and a current ratio of 1.08. The company has a fifty day moving average of $75.24 and a 200 day moving average of $66.03. Ceridian HCM has a fifty-two week low of $38.40 and a fifty-two week high of $87.00.
Ceridian HCM (NYSE:CDAY) last issued its earnings results on Wednesday, May 6th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.03. The company had revenue of $222.70 million during the quarter, compared to the consensus estimate of $218.42 million. Ceridian HCM had a net margin of 9.03% and a return on equity of 1.80%. Ceridian HCM’s quarterly revenue was up 9.3% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.14 EPS. Analysts forecast that Ceridian HCM will post 0.17 EPS for the current year.
In related news, major shareholder Cannae Holdings, Inc. sold 1,900,000 shares of the stock in a transaction dated Wednesday, May 20th. The shares were sold at an average price of $64.40, for a total value of $122,360,000.00. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Christopher R. Armstrong sold 11,071 shares of the firm’s stock in a transaction that occurred on Tuesday, May 5th. The stock was sold at an average price of $60.00, for a total transaction of $664,260.00. The disclosure for this sale can be found here. Insiders sold a total of 4,305,461 shares of company stock worth $285,602,275 over the last three months. 17.60% of the stock is currently owned by corporate insiders.
Large investors have recently modified their holdings of the company. Nuveen Asset Management LLC increased its position in shares of Ceridian HCM by 4.4% during the first quarter. Nuveen Asset Management LLC now owns 330,626 shares of the company’s stock worth $16,555,000 after acquiring an additional 13,950 shares during the period. Teza Capital Management LLC bought a new position in shares of Ceridian HCM during the first quarter valued at approximately $220,000. Nelson Van Denburg & Campbell Wealth Management Group LLC boosted its stake in shares of Ceridian HCM by 14.4% during the second quarter. Nelson Van Denburg & Campbell Wealth Management Group LLC now owns 4,530 shares of the company’s stock valued at $359,000 after purchasing an additional 570 shares in the last quarter. Alliancebernstein L.P. boosted its stake in shares of Ceridian HCM by 1.6% during the first quarter. Alliancebernstein L.P. now owns 169,482 shares of the company’s stock valued at $8,486,000 after purchasing an additional 2,640 shares in the last quarter. Finally, Swiss National Bank boosted its stake in Ceridian HCM by 139.3% in the first quarter. Swiss National Bank now owns 195,500 shares of the company’s stock valued at $9,789,000 after acquiring an additional 113,800 shares in the last quarter. 89.00% of the stock is currently owned by institutional investors and hedge funds.
About Ceridian HCM
Ceridian HCM Holding Inc operates as a human capital management (HCM) software company in the United States and internationally. The company offers Dayforce, a cloud HCM platform that provides human resources (HR), payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud platform, which offers scalable and straightforward payroll and HR solutions.
Recommended Story: What Every Investor Needs to Understand About Secondary Public Offerings
Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.